Cemiplimab for Basal Cell Carcinoma User Reviews
Brand names: Libtayo
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Basal Cell Carcinoma
Care guides
Symptoms and treatments
More about cemiplimab
- Check interactions
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Libtayo (cemiplimab) "I've been on Libtayo since June 2022. Every 3 weeks. It's working very well and the main side effect is the horrible itching just about everywhere. I had BCC very badly. My oncologist said it was the worst case he had ever seen in his career. I was seeing a dermatologist at first and he had me on pill-based chemotherapy (Erivedge, I think) that was horrible, and it did not work after 10 months. I lost 40 lbs and felt like I was dying. As the sores turned into tumors, he gave up and sent me to an oncologist and then I had to have incision surgery to remove the tumors. The BCC had gone onto my skin very deep and was a major concern. The Libtayo was a lifesaver for sure. The schedule is for 2 years of treatment. I'm 18 months into treatment and doing well. I get CT scans every 12 weeks to monitor progress, which the doctor says I'm responding to very well. The itching has been my only problem, and Fexofenadine helps with it."